Showing results (1-10 of 15) with videos related to
Sort By:
Pageof 2
Clinical Medicine (London, England)|February 3, 2016
Lesson of the month 2: Cauda equina in Cushing's syndromeDouglas Maslin, Ioannis Gounaris, Kenrick Ng, et al.Journal of Medical Economics|May 27, 2026
Budget impact analysis of delgocitinib for moderate to severe Chronic Hand Eczema in the United StatesJianni Singh-Landa, Aseel Bin Sawad, Yasmin Bappoo, et al.BMJ (Clinical Research Ed.)|October 14, 2010
Patients' experience and satisfaction in primary care: secondary analysis using multilevel modellingChris Salisbury, Marc Wallace, Alan A MontgomeryJournal of the Medical Library Association : JMLA|October 21, 2004
Findings from the most recent Medical Library Association salary surveyMarc Wallace, Thomas D McMullen, Kate CorcoranFrontiers in Medicine|May 30, 2024
A randomized, double-blinded, phase 2 trial of EDP1815, an oral immunomodulatory preparation of Prevotella histicola, in adults with mild-to-moderate plaque psoriasisBenjamin D Ehst, Bruce Strober, Andrew Blauvelt, et al.BMJ Case Reports|March 16, 2012
Warfarin, head injury and bruisingMarc Wallace, Emma D'Amato, Jasroop Chana, et al.Contact Dermatitis|March 3, 2026
Effect of Delgocitinib Cream on Health-Related Quality of Life in Patients With Moderate to Severe Chronic Hand EczemaAndrea Bauer, Lyn Guenther, Richard Woolf, et al.Dermatology and Therapy|June 12, 2026
Patient Preferences for Treatment Attributes in Moderate to Severe Chronic Hand Eczema: A Discrete Choice ExperimentApril W Armstrong, Aseel Bin Sawad, Nisha C Hazra, et al.Dermatology and Therapy|November 15, 2025
Matching-Adjusted Indirect Comparison of the Efficacy of Delgocitinib Cream and Dupilumab in the Treatment of Moderate to Severe Atopic Hand EczemaDavid Cohen, Anthony Bewley, Andreas Wollenberg, et al.Dermatology and Therapy|May 17, 2026
Minimal Systemic Exposure with Maximal Delgocitinib Cream Use in Patients with Severe Chronic Hand Eczema in the DELTA 2 Randomized, Vehicle-Controlled, Double-Blind, Phase 3 TrialMelinda Gooderham, Christopher G Bunick, JiaDe Yu, et al.Pageof 2